Inte, Marina L.
HRN: 25-25-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/09/2024
06/15/2024
IV
1.5gm
Q8
Cellulitis Right Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes